Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States

Emerging Infectious Diseases
Cheryl P AndamWilliam P Hanage

Abstract

Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

References

Jun 1, 1983·The Journal of Infectious Diseases·P S VenkateswaranR Austrian
Feb 24, 2010·The Journal of Infectious Diseases·Robert E GertzUNKNOWN Active Bacterial Core Surveillance Team
Apr 16, 2011·Lancet·Daniel M WeinbergerMarc Lipsitch
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lauri A HicksUNKNOWN Active Bacterial Core Surveillance (ABCs) Team
Sep 24, 2011·Human Vaccines·Johanna M C JefferiesStuart C Clarke
May 7, 2013·Nature Genetics·Nicholas J CroucherMarc Lipsitch
Mar 5, 2014·Antimicrobial Agents and Chemotherapy·Katie J SudaThomas H Taylor

❮ Previous
Next ❯

Citations

Jul 10, 2018·The Journal of Antimicrobial Chemotherapy·Heather J AdamUNKNOWN Canadian Antimicrobial Resistance Alliance (CARA)
Oct 1, 2019·International Journal of Pediatric Otorhinolaryngology·Dylan A LevyRodney J Schlosser
May 5, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Maitane Ibar-BariainAlicia Rodríguez-Gascón
Dec 7, 2021·Frontiers in Cellular and Infection Microbiology·Antonio J Martín-Galiano, Ernesto García

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Matthew R Moore, Cynthia G Whitney
The Lancet Global Health
Robert Cohen, Corinne Levy
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Antoni PayerasMa Carmen Gallegos
The Journal of Infection
Carmen Muñoz-AlmagroCatalan study group of invasive pneumococcal disease
© 2022 Meta ULC. All rights reserved